| Product Code: ETC12011542 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Drug Repurposing Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Drug Repurposing Market - Industry Life Cycle |
3.4 Portugal Drug Repurposing Market - Porter's Five Forces |
3.5 Portugal Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.6 Portugal Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.7 Portugal Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Portugal Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Portugal Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Portugal Drug Repurposing Market Trends |
6 Portugal Drug Repurposing Market, By Types |
6.1 Portugal Drug Repurposing Market, By Approach |
6.1.1 Overview and Analysis |
6.1.2 Portugal Drug Repurposing Market Revenues & Volume, By Approach, 2021 - 2031F |
6.1.3 Portugal Drug Repurposing Market Revenues & Volume, By On-Target Repurposing, 2021 - 2031F |
6.1.4 Portugal Drug Repurposing Market Revenues & Volume, By Off-Target Repurposing, 2021 - 2031F |
6.1.5 Portugal Drug Repurposing Market Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031F |
6.1.6 Portugal Drug Repurposing Market Revenues & Volume, By Pathway-Based Repurposing, 2021 - 2031F |
6.2 Portugal Drug Repurposing Market, By Disease Area |
6.2.1 Overview and Analysis |
6.2.2 Portugal Drug Repurposing Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 Portugal Drug Repurposing Market Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031F |
6.2.4 Portugal Drug Repurposing Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.5 Portugal Drug Repurposing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3 Portugal Drug Repurposing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Portugal Drug Repurposing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 Portugal Drug Repurposing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.4 Portugal Drug Repurposing Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F |
6.3.5 Portugal Drug Repurposing Market Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031F |
6.4 Portugal Drug Repurposing Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Portugal Drug Repurposing Market Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031F |
6.4.3 Portugal Drug Repurposing Market Revenues & Volume, By High-Throughput Screening, 2021 - 2031F |
6.4.4 Portugal Drug Repurposing Market Revenues & Volume, By Biomarker-Based Repurposing, 2021 - 2031F |
6.4.5 Portugal Drug Repurposing Market Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2021 - 2031F |
7 Portugal Drug Repurposing Market Import-Export Trade Statistics |
7.1 Portugal Drug Repurposing Market Export to Major Countries |
7.2 Portugal Drug Repurposing Market Imports from Major Countries |
8 Portugal Drug Repurposing Market Key Performance Indicators |
9 Portugal Drug Repurposing Market - Opportunity Assessment |
9.1 Portugal Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
9.2 Portugal Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.3 Portugal Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Portugal Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Portugal Drug Repurposing Market - Competitive Landscape |
10.1 Portugal Drug Repurposing Market Revenue Share, By Companies, 2024 |
10.2 Portugal Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here